ACM Biolabs
Business Services · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
71 Nanyang Dr, Singapore, Central Singap...Phone Number
+65 62655646Website
www.acmbiolabs.comRevenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About ACM Biolabs
ACM Biolabs is a biotechnology company based in Singapore that specializes in innovative medicines through a next-generation polymer-based nanoparticle delivery technology platform. Founded in 2013, the company is focused on developing new therapeutics for various diseases using its proprietary ACM Biolabs Tunable Platform (ATP), which allows for the delivery of multiple drug payloads. Their technology aims to enhance the efficacy of vaccines and therapies, particularly in oncology and infectious diseases, while addressing challenges related to cold-chain storage. ACM Biolabs serves clients in the pharmaceutical and biotechnology sectors, with a commitment to improving patient access to advanced medical treatments.Explore more
ACM Biolabs Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ACM Biolabs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when ACM Biolabs launches new products
Check out if ACM Biolabs is spiking on competitors!
Check if ACM Biolabs has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
ACM Biolabs, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ACM Biolabs has new funding data
Click to see if ACM Biolabs had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at ACM Biolabs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on ACM Biolabs recently announced quarterly report
Recommended Actions
Find VP level buyers at ACM Biolabs
Find 3 more new buyers
Company Profile Activity
Activity Insights
ACM Biolabs is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ACM Biolabs is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ACM Biolabs.
ACM Biolabs Tech Stack
A closer look at the technologies used by ACM Biolabs
See more technologies
ACM Biolabs News & Media
Cambridge’s DIOSynVax and Singapore’s ACM Biolabs to Advance Pandemic-Ready Universal Bird Flu Vaccine with International Support
CAMBRIDGE, United Kingdom and SINGAPORE, April 22, 2025 (GLOBE NEWSWIRE) -- Cambridge’s DIOSynVax and Singapore’s ACM Biolabs will be jointly developing a next-generation universal bird flu vaccine with the potential for mucosal delivery to combat the next pandemic. This bilateral project is supported by Innovate UK1 and Enterprise Singapore2, as part of the UK-Singapore Collaborative R&D Call.ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging early immunogenicity data ACM is in partnering...ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging early immunogenicity data ACM is in partnering discussions to provide new drug delivery solutions that address the most significant challenges faced using lipid nanoparticle-based (LNP) delivery systems SINGAPORE and BASEL, Switzerland and SYDNEY, Sept. 5, 2023 /PRACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging early immunogenicity data ACM is in partnering discussions to provide new drug delivery solutions that address the most significant challenges faced using lipid nanoparticle-based (LNP) delivery systems SINGAPORE and BASEL, Switzerland and SYDNEY, Sept. 5, 2023 /PR
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ACM Biolabs
Sign Up For FreeTo access detailed company insights
ACM Biolabs is a biotechnology company based in Singapore that specializes in innovative medicines through a next-generation polymer-based nanoparticle delivery technology platform. Founded in 2013, the company is focused on developing new therapeutics for various diseases using its proprietary ACM Biolabs Tunable Platform (ATP), which allows for t... Read More
